Literature DB >> 21508112

Serum carotenoids and risk of age-related macular degeneration in a chinese population sample.

Haiying Zhou1, Xianfeng Zhao, Elizabeth J Johnson, Apiradee Lim, Erdan Sun, Jie Yu, Yinbo Zhang, Xipu Liu, Torkel Snellingen, Fu Shang, Ningpu Liu.   

Abstract

PURPOSE: It has been hypothesized that the macular carotenoids protect against age-related macular degeneration (AMD). In this study, the association between serum concentrations of carotenoids and the presence of AMD was evaluated in a case-control sample of elderly Chinese subjects.
METHODS: Two hundred sixty-three individuals aged between 50 and 88 years enrolled in the study. Subjects included 82 cases with exudative AMD, 92 cases with early AMD, and 89 control individuals. Serum carotenoids (lutein, zeaxanthin, lycopene, α- and β-carotenes, and β-cryptoxanthin) and retinol were measured with reversed-phase high-performance liquid chromatography (HPLC).
RESULTS: Serum levels of carotenoids and retinol were significantly lower in the cases with exudative AMD than in the controls. Median levels of lutein and zeaxanthin were 0.538 and 0.101 μM, respectively, in the control subjects, and 0.488 and 0.076 μM, respectively, in cases with exudative AMD. After adjustment for age, sex, smoking status, and body mass index (BMI), a significant inverse association was observed for exudative AMD with serum zeaxanthin (relative risk ratio [RRR], 0.04; 95% confidence interval [CI], 0-0.35), lycopene (RRR, 0.22; 95% CI, 0.1-0.48), and α-carotene (RRR, 0.24; 95% CI, 0.12-0.51). Early AMD was inversely associated only with lycopene (RRR, 0.49; 95% CI, 0.28-0.86) but was positively associated with α-carotene (RRR, 2.22; 95% CI, 1.37-3.58). No significant associations were observed between serum lutein and cases with early or exudative AMD.
CONCLUSIONS: The data suggest that higher levels of serum carotenoids, in particular zeaxanthin and lycopene, are associated with a lower likelihood of having exudative AMD. Serum levels of carotenoids were relatively higher in this Chinese cohort than in samples of other ethnicities in previous reports.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508112     DOI: 10.1167/iovs.10-6519

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  Absorption, metabolism, and functions of β-cryptoxanthin.

Authors:  Betty J Burri; Michael R La Frano; Chenghao Zhu
Journal:  Nutr Rev       Date:  2016-01-07       Impact factor: 7.110

2.  Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.

Authors:  Juan Wu; Eunyoung Cho; Walter C Willett; Srinivas M Sastry; Debra A Schaumberg
Journal:  JAMA Ophthalmol       Date:  2015-12       Impact factor: 7.389

3.  Triple combination therapy and zeaxanthin for the treatment of neovascular age-related macular degeneration: an interventional comparative study and cost-effectiveness analysis.

Authors:  R Joseph Olk; Enrique Peralta; Dennis L Gierhart; Gary C Brown; Melissa M Brown
Journal:  Int J Retina Vitreous       Date:  2015-11-09

4.  Efficacy of Commercially Available Nutritional Supplements: Analysis of Serum Uptake, Macular Pigment Optical Density and Visual Functional Response.

Authors:  Richard A Bone; Pinakin Gunvant Davey; Betzabe O Roman; David W Evans
Journal:  Nutrients       Date:  2020-05-06       Impact factor: 5.717

5.  Rhizoma Paridis total saponins alleviate H2O2‑induced oxidative stress injury by upregulating the Nrf2 pathway.

Authors:  Baocheng Zhao; Zhenjun Wang; Jiagang Han; Guanghui Wei; Bingqiang Yi; Zhulin Li
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

Review 6.  Age-Related Macular Degeneration: What Do We Know So Far?

Authors:  Ho Hin Ma; Rasa Liutkevičienė
Journal:  Acta Med Litu       Date:  2021-01-18

Review 7.  Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.

Authors:  Ronald P Danis; Jeremy A Lavine; Amitha Domalpally
Journal:  Clin Ophthalmol       Date:  2015-11-20

8.  Plasma proteins associated with circulating carotenoids in Nepalese school-aged children.

Authors:  Abdulkerim Eroglu; Kerry J Schulze; James Yager; Robert N Cole; Parul Christian; Bareng A S Nonyane; Sun Eun Lee; Lee S F Wu; Subarna Khatry; John Groopman; Keith P West
Journal:  Arch Biochem Biophys       Date:  2018-03-30       Impact factor: 4.013

9.  Visual Function and Macular Carotenoid Changes in Eyes with Retinal Drusen-An Open Label Randomized Controlled Trial to Compare a Micronized Lipid-Based Carotenoid Liquid Supplementation and AREDS-2 Formula.

Authors:  Pinakin Gunvant Davey; Thomas Henderson; Drake W Lem; Rebecca Weis; Stephanie Amonoo-Monney; David W Evans
Journal:  Nutrients       Date:  2020-10-26       Impact factor: 5.717

Review 10.  Discovering the Potential of Natural Antioxidants in Age-Related Macular Degeneration: A Review.

Authors:  Kah-Hui Wong; Hui-Yin Nam; Sze-Yuen Lew; Murali Naidu; Pamela David; Tengku Ain Kamalden; Siti Nurma Hanim Hadie; Lee-Wei Lim
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.